Male albino rats weighing 200 to 300 g were used. The spinal cord was sectioned at the level between C11 and C111 under urethane anesthesia (1.0 g/kg, i.p.) and thirty minutes were allowed prior to injection of drug. Physostigmine salicylate, prostigmine methylsulfate and adrenaline hydrochloride were injected into the external jugular vein. Five or thirty minutes after the injection, the chest was opened and the heart was cut out as fast as possible for the determination of phosphorylase activity. Atropine sulfate or hexamethonium was given intravenously prior to administration of physostigmine.
Reserpinization was made 24 hours previously. The isolated heart was frozen in a mixture of alcohol-dry ice, and phosphorylase determination was made according to the method of Cori and Illingworth (10) . The detail of the procedures was described previously (1).
RESULTS

Effects of vagal stimulation and physostigmine in intact rats
Control experiments were made on urethane anesthetized intact rats. The activity of phosphorylase a (% of total) in the heart at 5 minutes after intravenous injection of saline solution (1.0 ml/kg) was 60.5±1.53%, which approximated to the value of the heart enzyme in the urethane anesthetized open-chest rat in the previous report.
Electrical stimulation (20/sec, 1 msec, submaximal) of the right vagus induced . usually bradycardia on ECG. Thirty seconds after onset of the bradycardia, the chest was opened and the heart was cut out for freezing. The activity of heart phosphorylase a fell to 44.5±0.99%. On the other hand, physostigmine (100.0 ,ug/kg) produced an increase of heart phosphorylase a to 79.8± 1.01% (Table 1) . * : Compared to Saline 1 ml/kg .
The heart was extirpated for the determination of phosphorylase at 5 minutes after injection, and this is the same in all following tables unless otherwise noted.
Effects of physostigmine, prostigmine and vagal stimulation in spinal rats
In anesthetized spinal rats, the activity of heart phosphorylase a at 5 minutes after injection of saline (1.0 ml/kg) was 60.6±3.69%. This value was nearly equal to the corresponding value in anesthetized intact rats, and this will be, unless otherwise stated, referred to the control in following descriptions.
Since physostigmine produced the, increase of heart, phosphorylase a in the intact, rats, the effect of physostigmine on the enzyme activity was first tested in the heart of spinal rat. The intravenous injection of physostigmine in a dose of 10.0 /tg/kg resulted in a significant increase of the heart enzyme from 60.6±3.69% to 73.0±1.48%. With an increase of the dose to 100.0 pg/kg, the enzyme activity rose to 85.9±4.40% and a marked elevation of 78.3±5.23% was still maintained 30 minutes later. On the other hand, prostigmine (50.0 beg/kg) decreased the enzyme activity to 42.5±6.41%. While nitrogen atom in the tertiary amine of physostigmine was tentatively considered to be responsible for the effect on the heart enzyme activity of physostigmine different from prostigmine, a quaternary ammonium, another peculiar finding was encountered. When the heart was removed from the spinal rat 30 seconds after the appearance of marked bradycardia following vagal stimulation, the heart enzyme activity was 86.7±2.97%. These results are summarized in Table 2 . . effects of atropine on the action of physostigmine To determine whether the increase in heart phosphorylase a activity caused by physostigmine was derived from endogenously liberated acetylcholine, atropine (0.5 mg/kg) was injected into rats 10 minutes prior to spinal section and thus total 45 minutes were allowed to elapse before physostigmine. In atropinized rats, the control value of saline (1.0 ml/kg) for heart phosphorylase a was 66.4±4.15%, which did not significantly differ from the corresponding value of non-atropinized rats. Physostigmine in a dose of 100.0 t g/kg again produced a marked increase in the heart enzyme, 82.7-{-0.79% (Table 3) . The value approximated to that after the injection of 100.0 ag/kg of physostigmine in non-atropinized spinal rats.
Effects of adrenaline, reserpine and hexamethonium on the action of physostigmine
In an attempt to find a correlation of the phosphorylase-activating action of physo stigmine with catecholamine, the following series of experiments were carried out. Adrenaline (1.0 ,t g/kg) alone increased the activity of heart phosphorylase in spinal rats to 73.0±4.47%. When physostigmine (10.0 jeg/kg) was given simultaneously with adrenaline (1.0 ,ug/kg) to spinal rats, heart phosphorylase a activity decreased from a control value of 60.6±3.69% to 40.4±1.21%. In animals injected with 50.0 /,2g/kg of physostigmine and 10.0 ,ug/kg of adrenaline simultaneously, the phosphorylase a activity was 55.8±3.26%. This value was also less than that after physostigmine or adrenaline alone.
Reserpine was given intraperitoneally in doses of 1.0 or 5.0 mg/kg 24 hours prior to spinal section. It was found that whereas 1.0 mg/kg of reserpine failed to affect the increase in heart phosphorylase a activity due to physostigmine, a larger dose (5.0 mg/kg) of reserpine prevented the effect of physostigmine of the heart enzyme, 42.6--X4.55%.
In order to exclude the possibility that the ganglionic stimulating action of physo stigmine was responsible for the increase in activity of heart phosphorylase a, hexa methonium was injected intravenously in a dose of 1.0 mg/kg 10 minutes prior to injection of physostigmine. This dose of hexamethonium, which was presumably enough to block ganglionic transmission, did not prevent the action of physostigmine on the heart enzyme. These results are shown in Table 4 . 
DISCUSSION
From the results obtained in the previous experiments (1), it has been suggested that some cholinergic reflex mechanism is involved in the effect of adrenaline on heart phosphorylase a. In the present experiment, it was expected that studies of anticholin esterase agents on the heart enzyme might give a clue to the role of endogenously liberated acetylcholine in formation of cyclic 3',5'-AMP. To eliminate the possibility that the central nervous system might effect the action on anticholinesterase, spinal rats were used. The control value of heart phosphorylase a in spinal rats was less than that in the unanesthetized, decapitated rats and approximated to that of the open chest preparation under urethane anesthesia (group 1 and 2 respectively, in the previous report). However, the control value of the enzyme activity in the spinal rat was very close to that of the intact rat, indicating that a 30 minutes interval is practically sufficient for stabilization of the preparation after surgical procedure. Although, so far as the author knows, no report has appeared regarding the effect of spinal section on heart phosphorylase a activity, hypotension induced by acute hemorrhage was reported to be without effect on the enzyme activity (5, 7).
In contrast to the significant decrease in heart phosphorylase a caused by prostigmine, injection of physostigmine and stimulation of the vagus nerve in the spinal rats caused an unexpected increase in the enzyme activity. In the open-chest rats the decrease in the enzyme activity following vagal stimulation and injection of acetylcholine or carbachol has been demonstrated by Hess et al. (7) . The present results on vagal stimula tion of the intact rat confirmed the decrease in heart phosphorylase a activity. Thus, it is likely that vagal stimulation exerts opposite effects on the enzyme activity: the activating effect in spinal rats, and the inhibitory one in intact rats. Apart from the mechanism of two phases of effect of vagal stimulation, the injection of physostigmine produced the increase in heart phosphorylase a activity in both preparations.
The heart phosphorylase activation induced with physostigmine would not be of central nervous origin, because the activation was obtained in spinal rats. The possibility that the cholinergic action would be responsible for the enzyme activation of physostigmine was also excluded, since the activation was not affected by prior injection of atropine.
Consequently, it is likely that physostigmine activates heart phosphorylase a through an unknown mechanism of peripheral origin. Many investigators (11) (12) (13) (14) reported that pressor response to physostigmine in rats resulted from an activation of the central sympathetic mechanism. Toda et al. (15) in this laboratory have shown that vagal stimulation of the isolated rabbit atria produces the positive ino and chrono-tropic effects and the effects are prevented by reserpinization. Along with this the activating effect of vagal stimulation on heart phosphorylase a in the spinal rat suggested that there might be adrenergic fibers or mechanism in the cholinergic innervation within the heart. Gokhale et al. (16) have shown that the pressor effect of physostigmine is reduced by antiadrenergic agents, hexamethonium, bretylium or guanethidine. There fore, it is possible to assume that the phosphorylase-activating action of physostigmine derives from noradrenaline or adrenaline endogenously liberated.
There are several factors which increase heart phosphorylase a (17) : 1) increase in synthesis of cyclic 3',5'-AMP resulting from activation of adenyl cyclase (catecholamine like), ,d and conversely from inhibition of phosphodiesterase (xanthine-like), 2) direct activation of conversion of , phosphorylase b to a caused by increase in activity of dephospho-phosphorylase kinase (ATP, Mg", Ca", Mn'-like), and prevention of opposite conversion of phosphorylase , caused by inhibition of, phosphorylase phosphatase (NaF like). While theophylline potentiated the adrenaline-induced phosphorylase activation (18) , combined administration of physostigmine and, adrenaline. resulted in a decrease of heart phosphorylasey a. Therefore, it is unlikely that phosphodiesterase is primarily involved in the, increase in heart phosphorylase a produced by physostigmine.
The finding that the action of physostigmine on heart phosphorylase was not blocked by hexamethonium,eliminates an, action through ganglionic stimulation of physostigmine. However, the possibility of adrenergic effect of physostigmine on the postganglionic
